Unique ID issued by UMIN | UMIN000033686 |
---|---|
Receipt number | R000038406 |
Scientific Title | Investigation for the anti-fatigue effects of ingestion of drinks in workers |
Date of disclosure of the study information | 2019/03/31 |
Last modified on | 2019/04/26 13:55:48 |
Investigation for the anti-fatigue effects of ingestion of drinks in workers
Anti-fatigue effects of drinks
Investigation for the anti-fatigue effects of ingestion of drinks in workers
Anti-fatigue effects of drinks
Japan |
Healthy Person
Adult |
Others
NO
To Investigation for the anti-fatigue effects of ingestion of drinks in workers
Efficacy
Changes in autonomic nerve function and cognitive function before and after the administration
Subjective fatigue
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Administration of 150 ml of test drink / Administration of 150 ml of placebo drink1 / Administration of 150 ml of placebo drink2
Administration of 150 ml of placebo drink1 / Administration of 150 ml of placebo drink2 / Administration of 150 mil of test drink
Administration of 150 ml of placebo drink2 / Administration of 150 ml of test drink / Administration of 150 ml of placebo drink1
20 | years-old | <= |
50 | years-old | > |
Male and Female
1. Healthy persons who are aged from 20 to 49 years.
2. Persons who are full-time worker on the day shift.
3. Persons who can give written informed consents.
1. Persons who have previous history such as neurological disorder, nervous system disorder, cardiovascular disease, and other serious disease.
2. Persons who have previous history of nervous system disease such as unconsciousness, coma, convulsion, etc.
3. Persons who are in treatment.
4. Persons who usually take in health foods and supplements.
5. Persons who have food allergy.
6. Persons who have vision disorder or auditory disorder.
7. Persons who are pregnant or breastfeed.
8. Persons who can't drink soda.
9. Persons who had ever felt sick during a blood test.
10. Persons who are now participating in other clinical trials, or participated in other clinical trials within a month before obtaining his/her informed consent in this trial.
11. Persons who are judged not suitable to participate in this trial by investigators.
30
1st name | Kei |
Middle name | |
Last name | Mizuno |
RIKEN
Health Evaluation Team
650-0047
6-7-1 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN
078-569-8868
keimizuno@riken.jp
1st name | Kei |
Middle name | |
Last name | Mizuno |
RIKEN
Health Evaluation Team
650-0047,
6-7-1 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN
078-569-8868
keimizuno@riken.jp
RIKEN Health Evaluation Team
ASAHI SOFT DRINKS CO., LTD.
Profit organization
RIKEN
2-2-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JAPAN
078-306-3036
kobe-ankan@cdb.riken.jp
NO
国立研究開発法人理化学研究所(兵庫県)
2019 | Year | 03 | Month | 31 | Day |
Unpublished
29
Completed
2018 | Year | 07 | Month | 04 | Day |
2018 | Year | 07 | Month | 04 | Day |
2018 | Year | 08 | Month | 25 | Day |
2018 | Year | 09 | Month | 15 | Day |
2018 | Year | 08 | Month | 08 | Day |
2019 | Year | 04 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038406